SUMMARY Our previous cerebral ultrasound study of antecedents of periventricular haemorrhage in infants weighing 1250 g or less at birth suggested that neonatal events that caused increased or fluctuating cerebral blood flow lead to periventricular haemorrhage. As the risk period for this type of haemorrhage was the first four days of life strict guidelines were introduced to avoid the previously identified neonatal risk factors. No attempt was made to modify obstetric practice. Over the next two years, although the obstetric risk profile, the frequency and severity of hyaline membrane disease, and the gestation, birth weight, and sex distributions of a similar cohort of infants did not change, the incidence of periventricular haemorrhage decreased significantly from 60% to 36%. Significant antecedents of haemorrhage similar to those found in the previous study included severe bruising, low arterial:fractional inspiratory oxygen ratio and low packed cell volume on admission, hyaline membrane disease, hypercarbia, and hypoxaemia. Assisted ventilation, pneumothorax, treatment with tubocurarine, and hypotension were no longer significant risk factors for periventricular haemorrhage. A multivariate discriminant analysis correctly predicted haemorrhage in 86% of the study group when bruising, hypercarbia, hypoxaemia, hyaline membrane disease, and low gestation were considered. These results suggest that changes in neonatal practices can reduce the incidence of periventricular haemorrhage and that drug studies indicating similar reductions in haemorrhage need to be evaluated carefully to ensure that placebo and treated groups are in fact comparable.
The use of serial real time cerebral ultrasonography has allowed antecedents of periventricular haemorrhage to be distinguished fronm its associates in preterm infants.' 2 At the same time several groups have claimed significant reduction in incidence of periventricular haemorrhage by the use of phenobarbitone, ethamsylate, vitamin E, pancuronium, and fresh frozen plasma.39 Some of these studies have not scanned the infants before enrolment in the drug study and others have not indicated whether the placebo and treated groups had a similar distribution of antecedents for periventricular haemorrhage, making interpretation of their results difficult. In the present study we determined the incidence and severity of periventricular haemorrhage and its antecedent factors after introducing strict guidelines to avoid the previously identified antecedents of the haemorrhage.
Patients and methods
All infants admitted to the neonatal intensive care unit at Queen Victoria Medical Centre in the years 1983-84 weighing 1250 g or less at birth were included in the study. Excluded from the study were three infants with multiple congenital anomalies, two infants with central nervous system anomalies, and two infants who died shortly after admission before a cerebral ultrasound scan (20 and 60 minutes of age, respectively). One hundred infants were scanned as soon as possible after birth, eight to 12 hourly until 72 hours of age, daily until one week of age, and weekly thereafter until discharge.
A Toshiba SAL 120 real time linear array scanner with a 5 MHz transducer and an ATL MK 600 real time sector scanner with 5 and 7-5 MHz transducers were used to obtain images in coronal, sagittal, and axial planes as previously described.10 Our correlation of ultrasound with necropsy findings for periventricular haemorrhage was over 90%. Germinal layer haemorrhage was defined as bleeding into the germinal layer overlying the caudate nucleus, intraventricular haemorrhage as any amount of blood seen in the ventricular system, and intracerebral haemorrhage as bleeding into the brain parenchyma. Periventricular leucomalacia with cystic degeneration was also identified on serial scanning.
After antecedents of periventricular haemorrhage had been identified in a cohort of infants -1250 g born in 19821 strict guidelines for neonatal care were introduced in January 1983 in an attempt to decrease the frequency of these risk factors. Resuscitation at delivery included the use of elective intubation and sodium bicarbonate to correct acidosis if the infant was not breathing spontaneously by 3 minutes of age. This was a change from the previous routine when intubation was periventricular haemorrhage suggest improvement in neonatal care. The overall incidence of periventricular haemorrhage was significantly lower in cohort 2 compared with cohort 1 (36% v 60%, p<0001). Table 4 shows that the incidence of periventricular haemorrhage was lower across all birthweight and gestation subgroups, as was the incidence of periventricular leucomalacia.
The analysis to determine antecedents of periventricular haemorrhage identified many similar risk factors in both cohorts 1 and 2. In both cohorts the only significant obstetric risk factor for periventricular haemorrhage was birth trauma (p<0-005) as evidenced by severe bruising of the head. The significant intrapartum and neonatal antecedents of periventricular haemorrhage common to both cohorts included low admission arterial:fractional inspiratory oxygen ratio (p<00125) and packed cell volume (p<0025); hyaline membrane disease (p<00125), hypercarbia (p<0.0005), and hypoxaemia (<0.005). Case control studies in subgroups of similar gestation (24-25, 26-27, and 28 weeks) and birth weight (655 (SD 82) g, 936 (162) g, and 988 (248) g) confirmed that the above antecedents were independent of the degree of prematurity. Neonatal factors that were significant antecedents of periventricular haemorrhage in cohort 1 but were no longer found to be significant in cohort 2 were mechanical ventilation, pneumothorax, administration of tubocurarine, low body temperature, and systemic hypotension. Analysis of the 16 infants who had a pneumothorax in cohort 2 showed that the eight infants who then developed periventricular haemorrhage were affected in a significantly different manner from those who did not develop haemorrhage. The effects of the pneumothorax were more pronounced in those with periventricular haemorrhage. These were higher peak arterial carbon dioxide tensions (86.5 (SD 37-7) v 54 6 (7.8) [12] [13] [14] [15] [16] regarding the importance of these events as antecedents of periventricular haemorrhage. In our cohort the use of vasoactive drugs, including tubocurarine, pancuronium, dopamine, tolazoline, and indomethacin, during the vulnerable first four days of life does not increase the incidence of periventricular haemorrhage if every effort is made to maintain the infant's cardiorespiratory variables within normal limits.
Our analysis of obstetric events could not determine the importance of neonatal transport as 90% of cohorts 1 and 2 were inborn or antenatal steroids as less than 10% of cohorts 1 and 2 received betamethasone. Some published reports have suggested that prolonged labour was a significant antecedent of periventricular haemorrhage,'7 18 while another study reached the opposite 'conclusion. 16 In both our cohorts prolonged labour whether defined as greater than six hours'7 or greater than 12 hours'8 was not a significant antecedent unless accompanied by severe bruising of the head. The varying effects and degree of trauma associated with prolonged labour in preterm infants probably explain the conflicting opinions as to its importance in the pathogenesis of periventricular haemorrhage.
Defects in haemostasis, including coagulopathy, thrombocytopenia, and platelet dysfunction, have been associated with periventricular haemorrhage.19 20 We found, however, that the platelet count, prothrombin time, or partial thromboplastin concentrations on admission, and thrombocytopenia or disseminated intravascular coagulation in the first four days of life were not significant antecedents of periventricular haemorrhage. Contrary to a recent report,9 the use of fresh frozen plasma on day 1 was not associated with a lower incidence of periventricular haemorrhage in our cohort.
The incidence of periventricular haemorrhage in cohorts that included larger infants up to 1500 g birth weight (very low birth weight) has varied from 43-55% 12 15 16 21 In the two studies that have data on infants less than 1000 g the incidence of peniventricular haemorrhage ranged from 61-70%.2 15 In a recent review reporting pooled data from six centres the incidence of periventricular haemorrhage over a wide gestational range was reported as 77% (96/125) in preterm infants of -26 weeks' gestation, 56% (102/182) in those of 27-28 weeks' gestation, 37% (84/228) in those of 29-30 weeks' gestation, 26% (62/239) in those of 31-32 weeks' gestation, and 7% (11/150) in those of -33 weeks' gestation.22 Compared with this pooled data, the incidence of periventricular haemorrhage at our hospital was significantly lower after introduction of guidelines aimed at reducing the frequency of factors that cause increases and fluctuations in cerebral blood flow. Our incidence of periventricular haemorrhage was 50% (13/26, p<0005) in preterm infants of -26 weeks' gestation, 36% (20/56, p<0-005) in those of 27-28 weeks' gestation, 16% (11/68, p<0O0025) in those of 29-30 weeks' gestation, 5% (6/121, p<00005) in those of 31-32 weeks' gestation, and 2% (2/100, p<0-05) in those significant reduction in incidence of periventricular haemorrhage in very low birthweight infants to 16%7 and 13%3 after use of vitamin E and phenobarbitone are difficult to interpret as the infants were not scanned before enrolment into placebo or treatment groups. In a cohort of similar gestation and birth weight to these reports3 7 our incidence of periventricular haemorrhage was 24% (47/196). In studies where infants were scanned before enrolment into placebo or treatment groups the incidence of periventricular haemorrhage in treated groups was 48% (10/21) with phenobarbital,4 23% (10/43) with ethamsylate,S 43%(9/21) with vitamin E,6 36% (5/14) with pancuronium,8 and 14% (5/36) with fresh frozen plasma.9 Our incidence of periventricular haemorrhage without use of treatment with drugs or fresh frozen plasma in identical groups to those reported46 8 9 was equally low after the introduction of strict guidelines for neonatal care, being 17% (50/289), 24% (44/183), 20% (50/255), 22% (40/183). and 20% (47/241), respectively.
As neonatal practices change rapidly as more experience accumulates in the treatment of very and extremely low birthweight infants it is important that the effects of these changes are not overlooked when a prophylactic drug for prevention of periventricular haemorrhage is introduced. Our risk factor analysis showed the importance of matching groups for all known antecedents of periventricular haemorrhage and for disturbances of blood gases and blood pressure and not only for birth weight and gestation before any conclusions regarding drug efficacy can be reached. As the neurodevelopmental outcome of extremely preterm or low birthweight infants is closely related to the degree of periventricular haemorrhage and periventricular leucomalacia2325 the reduction of their incidence whether by changes in neonatal management or by treatment with drugs should lead to decreased long term disability in the more recent survivors.
haemorrhage in preterm infants. 
Reduction in periventricular

